Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Stryckmans

Showing results (31-40 of 131) with videos related to

Pageof 14
Sort By:
Cytokine|May 1, 1993
Efficacy and safety of cytokines for human therapy. Report of an EC Study GroupP Stryckmans, G W Duff, G N Fracchia
Acta Clinica Belgica|January 1, 1975
[Cell proliferation and action of chemotherapy in malignant lymphomas of the lymphocytic type in the leukemic phase]P Stryckmans, L Debusscher, G Delalieux, et al.
Acta Clinica Belgica|January 1, 1986
Fatal lactic acidosis in malignant histiocytosisF Ries, D Bron, M Bernier, et al.
Experimental Hematology|July 1, 1993
Cytomegalovirus-mediated myelosuppressionL Lagneaux, A Delforge, P Stryckmans, et al.
Bone Marrow Transplantation|May 1, 1996
Very low level of major BCR-ABL expression in blood of some healthy individualsC Biernaux, A Sels, G Huez, et al.
Cancer Chemotherapy Reports|November 1, 1975
Phase I-II clinical trial with mitoclomine (NSC-114575) in chronic lymphocytic leukemiaE Longeval, D Ganglji, P Stryckmans, et al.
Blood|December 1, 1970
The potentiality of out-of-cycle acute leukemic cells to synthesize DNAP Stryckmans, G Delalieux, J Manaster, et al.
Blood|January 1, 1985
Cyclosporine for pure red cell aplasiaL Debusscher, R Paridaens, P Stryckmans, et al.
Archives of Neurology|October 1, 1982
Acute nonlymphoblastic leukemia in a patient treated for brain tumorJ Hildebrand, M Malarme, J Flament-Durand, et al.
Journal of the National Cancer Institute|April 1, 1981
Chemotherapeutic sensitivity of normal and leukemic hematopoietic progenitor cells to N-[4-(9-acridinylamino)-3-methoxyphenyl]-methanesulfonamide, a new anticancer agentT E Spiro, M Socquet, A Delforge, et al.
Pageof 14

Showing results (31-40 of 131) with videos related to

Sort By:
Pageof 14
Cytokine|May 1, 1993
Efficacy and safety of cytokines for human therapy. Report of an EC Study GroupP Stryckmans, G W Duff, G N Fracchia
Acta Clinica Belgica|January 1, 1975
[Cell proliferation and action of chemotherapy in malignant lymphomas of the lymphocytic type in the leukemic phase]P Stryckmans, L Debusscher, G Delalieux, et al.
Acta Clinica Belgica|January 1, 1986
Fatal lactic acidosis in malignant histiocytosisF Ries, D Bron, M Bernier, et al.
Experimental Hematology|July 1, 1993
Cytomegalovirus-mediated myelosuppressionL Lagneaux, A Delforge, P Stryckmans, et al.
Bone Marrow Transplantation|May 1, 1996
Very low level of major BCR-ABL expression in blood of some healthy individualsC Biernaux, A Sels, G Huez, et al.
Cancer Chemotherapy Reports|November 1, 1975
Phase I-II clinical trial with mitoclomine (NSC-114575) in chronic lymphocytic leukemiaE Longeval, D Ganglji, P Stryckmans, et al.
Blood|December 1, 1970
The potentiality of out-of-cycle acute leukemic cells to synthesize DNAP Stryckmans, G Delalieux, J Manaster, et al.
Blood|January 1, 1985
Cyclosporine for pure red cell aplasiaL Debusscher, R Paridaens, P Stryckmans, et al.
Archives of Neurology|October 1, 1982
Acute nonlymphoblastic leukemia in a patient treated for brain tumorJ Hildebrand, M Malarme, J Flament-Durand, et al.
Journal of the National Cancer Institute|April 1, 1981
Chemotherapeutic sensitivity of normal and leukemic hematopoietic progenitor cells to N-[4-(9-acridinylamino)-3-methoxyphenyl]-methanesulfonamide, a new anticancer agentT E Spiro, M Socquet, A Delforge, et al.
Pageof 14